ATE432287T1 - Peptidfragmente mit den zelltod verhindernder aktivität - Google Patents

Peptidfragmente mit den zelltod verhindernder aktivität

Info

Publication number
ATE432287T1
ATE432287T1 AT99972642T AT99972642T ATE432287T1 AT E432287 T1 ATE432287 T1 AT E432287T1 AT 99972642 T AT99972642 T AT 99972642T AT 99972642 T AT99972642 T AT 99972642T AT E432287 T1 ATE432287 T1 AT E432287T1
Authority
AT
Austria
Prior art keywords
peptide fragments
amino acid
series
cell death
peptide
Prior art date
Application number
AT99972642T
Other languages
English (en)
Inventor
Masaki Hirashima
Hiroaki Maeda
Chikateru Nozaki
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE432287T1 publication Critical patent/ATE432287T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT99972642T 1998-11-19 1999-11-12 Peptidfragmente mit den zelltod verhindernder aktivität ATE432287T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34786398 1998-11-19
PCT/JP1999/006322 WO2000031131A1 (fr) 1998-11-19 1999-11-12 Fragments peptidiques a activite inhibitrice de la mort cellulaire

Publications (1)

Publication Number Publication Date
ATE432287T1 true ATE432287T1 (de) 2009-06-15

Family

ID=18393115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972642T ATE432287T1 (de) 1998-11-19 1999-11-12 Peptidfragmente mit den zelltod verhindernder aktivität

Country Status (8)

Country Link
US (2) US7199097B1 (de)
EP (1) EP1132402B1 (de)
JP (1) JP4485062B2 (de)
AT (1) ATE432287T1 (de)
AU (1) AU1179500A (de)
CA (1) CA2351558C (de)
DE (1) DE69940927D1 (de)
WO (1) WO2000031131A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067976A1 (fr) * 2001-02-28 2002-09-06 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Nouveaux inhibiteurs de lesion d'ischemie/reperfusion
EP1374887B1 (de) * 2001-03-23 2008-08-20 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Neue mittel zur linderung von motorischen störungen
WO2002076493A1 (fr) * 2001-03-23 2002-10-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Nouveaux medicaments pour la prevention/le traitement de maladies immunopathiques
US20050143310A1 (en) * 2001-05-11 2005-06-30 Masaki Hirashima Novel remedies for neurodegenerative disease
EP1386963A4 (de) * 2001-05-11 2005-03-23 Juridical Foundation Peptide mit zytotoxizität hemmender aktivität und verfahren zum screening dieser peptide mit zytotoxizität hemmender aktivität
ATE436023T1 (de) * 2001-05-16 2009-07-15 Xavier Forceville Verfahren für die in-vitro-diagnostik oder für die überwachung einer krankheit mit entzündungsreaktion
JP2003026598A (ja) * 2001-06-27 2003-01-29 Chemo Sero Therapeut Res Inst 新規なリウマチ予防・治療用薬剤
WO2003016347A1 (fr) * 2001-08-09 2003-02-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Procede de preparation d'un fragment peptidique presentant une activite inhibitrice de mort cellulaire
JP2004182616A (ja) * 2002-11-29 2004-07-02 Chemo Sero Therapeut Res Inst 新規な神経伝達機能異常疾患改善剤
WO2008122039A2 (en) 2007-04-02 2008-10-09 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Selenocysteine mediated hybrid antibody molecules
JP6370637B2 (ja) * 2013-08-27 2018-08-08 学校法人同志社 ２型糖尿病の治療及び／又は予防薬
CN114907445B (zh) * 2022-05-10 2023-06-06 华南农业大学 一种高抗氧化活性富硒肽及其应用

Also Published As

Publication number Publication date
US7199097B1 (en) 2007-04-03
US7598349B2 (en) 2009-10-06
WO2000031131A1 (fr) 2000-06-02
CA2351558A1 (en) 2000-06-02
EP1132402A4 (de) 2005-12-21
CA2351558C (en) 2010-01-12
EP1132402A1 (de) 2001-09-12
DE69940927D1 (de) 2009-07-09
JP4485062B2 (ja) 2010-06-16
AU1179500A (en) 2000-06-13
EP1132402B1 (de) 2009-05-27
US20050281808A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
ATE368053T1 (de) Antimikrobielle peptide
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
DK150992A (da) Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
ATE269902T1 (de) Cytokinähnliches polypeptid-10 aus säugetieren
ATE168719T1 (de) Osteogene peptide
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
DE69840509D1 (de) Apoptose-bezogene verbindungen und deren verwendung
ATE362939T1 (de) Dimere von thrombinpeptidderivaten
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
DE69432427D1 (de) Tomate xyloglukan endotransglykosylase
DE69607034D1 (de) Pcna bindende substanz
ATE374246T1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
TR200003498T2 (tr) Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid
DE60120391D1 (de) Verwendung von hev-polypeptiden
DK1158050T3 (da) Human cysteinyl-leukotrienreceptor (CysLT2)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1132402

Country of ref document: EP